Alnylam, German Group Settle RNA Patent App Case
Alnylam Pharmaceuticals Inc. and a German research organization on Tuesday settled their contract suit against a Massachusetts-based biomedical research group and a college trustee board over the prosecution of two families...To view the full article, register now.
Already a subscriber? Click here to view full article